Journal Article

Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction

Ambler, Gareth, Spencer, Rebecca, Weissbach, Tal, David, Anna L., Gratacós, Eduard, Marlow, Neil, Huertas-Ceballos, Angela, Brodszki, Jana, Hansson, Stefan R., Diemert, Anke, Maksym, Kasia, Nené, Nuno Rocha, Sebire, Neil J., Hecher, Kurt, Maršál, Karel, Zachary, Ian, Peebles, Donald M., Figueras, Francesc, Whitwell, Harry, Ginsberg, Yuval

2023

Overview

BACKGROUNDSevere, early-onset fetal growth restriction (FGR) causes significant fetal and neonatal mortality and morbidity. Predicting the outcome of affected pregnancies at the time of diagnosis is difficult, thus preventing accurate patient counseling. We investigated the use of maternal serum protein and ultrasound measurements at diagnosis to predict fetal or neonatal death and 3 secondary outcomes: fetal death or delivery at or before 28+0 weeks, development of abnormal umbilical artery (UmA) Doppler velocimetry, and slow fetal growth.METHODSWomen with singleton pregnancies (n = 142, estimated fetal weights [EFWs] below the third centile, less than 600 g, 20+0 to 26+6 weeks of gestation, no known chromosomal, genetic, or major structural abnormalities) were recruited from 4 European centers. Maternal serum from the discovery set (n = 63) was analyzed for 7 proteins linked to angiogenesis, 90 additional proteins associated with cardiovascular disease, and 5 proteins identified through pooled liquid chromatography and tandem mass spectrometry. Patient and clinician stakeholder priorities were used to select models tested in the validation set (n = 60), with final models calculated from combined data.RESULTSThe most discriminative model for fetal or neonatal death included the EFW z score (Hadlock 3 formula/Marsal chart), gestational age, and UmA Doppler category (AUC, 0.91; 95% CI, 0.86-0.97) but was less well calibrated than the model containing only the EFW z score (Hadlock 3/Marsal). The most discriminative model for fetal death or delivery at or before 28+0 weeks included maternal serum placental growth factor (PlGF) concentration and UmA Doppler category (AUC, 0.89; 95% CI, 0.83-0.94).CONCLUSIONUltrasound measurements and maternal serum PlGF concentration at diagnosis of severe, early-onset FGR predicted pregnancy outcomes of importance to patients and clinicians.TRIAL REGISTRATIONClinicalTrials.gov NCT02097667.FUNDINGThe European Union, Rosetrees Trust, Mitchell Charitable Trust.

• Publisher: American Society for Clinical Investigation
• Subject: Clinical Medicine / Female / Fetal Death / Fetal Growth Retardation - diagnostic imaging / Gynaecology, Obstetrics and Reproductive Medicine / Gynekologi, obstetrik och reproduktionsmedicin / Humans / Infant, Newborn / Klinisk medicin / Medical and Health Sciences / Medicin och hälsovetenskap / Perinatal Death / Placenta Growth Factor / Pregnancy / Pregnancy Outcome / Reproductive biology